Skip to main content
MJH Life Sciences
  • Login
  • Register
  • Login
  • Register
Home
  • ONCOLOGY
  • News
  • Blogs
  • Topics
  • Hematology
  • Image IQ
  • Podcasts
  • Videos
  • Slideshows
  • Conferences
MJH Life Sciences

SUBSCRIBE: Print / eNewsletter

Rates of Renal, Thyroid Carcinomas Increasing in Children, Adolescents

  • Leah Lawrence
September 16, 2014
  • Pediatric Cancers, Genitourinary Cancers, Kidney Cancer, Renal Cell Carcinoma, Thyroid Cancer

Results of a new study show that overall cancer rates among children and adolescents are stable, but that the incidence of certain cancers, including renal and thyroid carcinomas, are increasing.

“These findings highlight an opportunity to improve our knowledge of the driving factors of these cancer incidence rate trends, and this understanding may help develop new preventive measures,” wrote David A. Siegel, MD, MPH, of Emory University School of Medicine, and colleagues in Pediatrics.

Siegel and colleagues analyzed data taken from the National Program of Cancer Registries (NPCR) and Surveillance, Epidemiology, and End Results (SEER) registries to identified cancer diagnosed in patients aged 0 to 19 years between 2001 and 2009. According to the study, these registries represent 94.2% of the US population.

Using these registries, they identified 120,137 cases of cancer, with an age-adjusted incidence rate of 171.01 per million. Data showed that the incidence of cancer was higher in boys compared with girls, in adolescents compared with children, and in white children compared with black children. The most commonly occurring cancers were leukemia, followed by central nervous system neoplasms, and lymphomas.

The researchers found no significant change in the cancer incidence from 2001 to 2009 (annual percent change [APC], 0.3%; 95% CI, -0.1 to 0.7). However, they did find that the incidence of thyroid carcinoma (APC, 4.9%; 95% CI, 3.2 to 6.6) and renal carcinoma (APC, 5.4%; 95% CI, 2.8 to 8.1) had increased significantly.

“Rates of renal carcinomas, thyroid carcinomas, and other unspecified malignant neoplasms increased significantly for boys, and the trend for thyroid carcinoma increased significantly for girls,” the researchers wrote. “Increased rate of obesity among adolescents might explain increases in renal carcinomas observed overall and among those aged 15 to 19 years.”

In addition to the results about thyroid and renal carcinoma, the study also found an increasing trend in the overall cancer incidence among black children and adolescents (APC, 1.3%; 95% CI, 0.2 to 2.5). A significant decrease in melanoma was seen overall, as well as in boys, white patients, non-Hispanic patients, adolescents aged 15 to 19 years, and in the Northwest and West regions.

“It is possible that pediatric melanoma is decreasing after an increase seen at the end of the last century,” the researchers wrote. “However, melanoma is often an outpatient disease that adds registry data late into SEER and NPCR.”

Related Articles

  • Nivolumab Trial Failure Raises the Question of Brain Imaging in Kidney Cancer
  • Using Patient-Reported Outcomes to Reflect Post-Prostatectomy Sexual Function
  • What Is the Ideal Glucocorticoid Regimen Combined With Abiraterone for Prostate Cancer?
  • Maintaining Quality of Life With Darolutamide in Nonmetastatic Prostate Cancer
  • Counterpoint: Should Active Surveillance Be Used for Gleason 3+4 Prostate Cancer?

Resource Topics rightRail

  • Resource Topics
  • Partner Content
  • Breast Cancer
  • Acute Myeloid Leukemia
  • HER2-Positive Breast Cancer
  • Videos Breast Cancer
  • Follicular Lymphoma
Cutaneous T-Cell Lymphomas: Mycosis Fungoides and Sézary Syndrome
3 Keys to Success in the Oncology Care Model

Current Issue

ONCOLOGY Vol 33 No 11
Nov 21, 2019 Vol 33 No 11
Subscribe
Connect with Us
  • Column 1
    • Home
    • About Us
    • Contact Us
  • Column 2
    • Editorial Info
    • Editorial Board
  • Column 3
    • Advertising Info
    • Reprints
    • Advertising Terms
  • Column 4
    • Terms of Use
    • Privacy Policy
Modern Medicine Network
© UBM 2019, All rights reserved.
Reproduction in whole or in part is prohibited.

We've noticed that you're using an ad blocker

Our content is brought to you free of charge because of the support of our advertisers. To continue enjoying our content, please turn off your ad blocker.

It's off now Dismiss How do I disable my ad blocker?
❌

How to disable your ad blocker for our site:

Adblock / Adblock Plus
  • Click on the AdBlock / AdBlock Plus icon on the top right of your browser.
  • Click “Don’t run on pages on this domain.” OR “Enabled on this site.”
  • Close this help box and click "It's off now".
Firefox Tracking Prevention
  • If you are Private Browsing in Firefox, "Tracking Protection" may casue the adblock notice to show. It can be temporarily disabled by clicking the "shield" icon in the address bar.
  • Close this help box and click "It's off now".
Ghostery
  • Click the Ghostery icon on your browser.
  • In Ghostery versions < 6.0 click “Whitelist site.” in version 6.0 click “Trust site.”
  • Close this help box and click "It's off now".
uBlock / uBlock Origin
  • Click the uBlock / uBlock Origin icon on your browser.
  • Click the “power” button in the menu that appears to whitelist the current website
  • Close this help box and click "It's off now".